AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Schreij, G van der Geest, S Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals, J ACQ IMM D, 27(4), 2001, pp. 344-349
Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection
Authors: Sparidans, RW Hoetelmans, RMW Beijnen, JH
Citation: Rw. Sparidans et al., Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection, J CHROMAT B, 750(1), 2001, pp. 155-161
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
Authors: Foudraine, NA Jurriaans, S Weverling, GJ Burger, DM Hoetelmans, RMW Roos, MTL Maas, J Miedema, F Reiss, P Portegies, P de Wolf, F Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62
Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1
Authors: van Praag, RME van Heeswijk, RPG Jurriaans, S Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1, CLIN INF D, 33(8), 2001, pp. E91-E92
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
Authors: Koks, CHW Crommentuyn, KML Hoetelmans, RMW Burger, DM Koopmans, PP Mathot, RAA Mulder, JW Meenhorst, PL Beijnen, JH
Citation: Chw. Koks et al., The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals, BR J CL PH, 51(6), 2001, pp. 631-635
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
Authors: Veldkamp, AI Weverling, GJ Lange, JMA Montaner, JSG Reiss, P Cooper, DA Vella, S Hall, D Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals, AIDS, 15(9), 2001, pp. 1089-1095
Drug interaction between St John's wort and nevirapine
Authors: de Maat, MMR Hoetelmans, RMW Mathot, RAA van Gorp, ECM Meenhorst, PL Mulder, JW Beijnen, JH
Citation: Mmr. De Maat et al., Drug interaction between St John's wort and nevirapine, AIDS, 15(3), 2001, pp. 420-421
The ADAM study continued: maintenance therapy after 50 weeks of induction therapy
Authors: Reijers, MHE Weverling, GJ Jurriaans, S Roos, MTL Wit, FWNM Weigel, HM Ten Kate, RW Mulder, JW Richter, C Ter Hofstede, HJM Sprenger, H Hoetelmans, RMW Schuitemaker, H Lange, JMA
Citation: Mhe. Reijers et al., The ADAM study continued: maintenance therapy after 50 weeks of induction therapy, AIDS, 15(1), 2001, pp. 129-131
Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Hoetelmans, RMW Lange, JMA Beijnen, JH
Citation: Ai. Veldkamp et al., Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine, THER DRUG M, 23(6), 2001, pp. 606-611
Can fluconazole concentrations in saliva be used for therapeutic drug monitoring?
Authors: Koks, CHW Crommentuyn, KML Hoetelmans, RMW Mathot, RAA Beijnen, JH
Citation: Chw. Koks et al., Can fluconazole concentrations in saliva be used for therapeutic drug monitoring?, THER DRUG M, 23(4), 2001, pp. 449-453
Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Beijnen, JH Lange, JMA Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine, THER DRUG M, 23(3), 2001, pp. 255-258
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children
Authors: Burger, DM van Rossum, AMC Hugen, PWH Suur, MH Hartwig, NG Geelen, SPM Scherpbier, HJ Hoetelmans, RMW Vulto, AG de Groot, R
Citation: Dm. Burger et al., Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children, ANTIM AG CH, 45(3), 2001, pp. 701-705
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates
Authors: Rongkavilit, C Thaithumyanon, P Chuenyam, T Damle, BD Limpongsanurak, S Boonrod, C Srigritsanapol, A Hassink, EAM Hoetelmans, RMW Cooper, DA Lange, JMA Ruxrungtham, K Phanuphak, P
Citation: C. Rongkavilit et al., Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates, ANTIM AG CH, 45(12), 2001, pp. 3585-3590
Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma
Authors: van Praag, RME Repping, S de Vries, JWA Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma, ANTIM AG CH, 45(10), 2001, pp. 2902-2907
P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir
Authors: Huisman, MT Smit, JW Wiltshire, HR Hoetelmans, RMW Beijnen, JH Schinkel, AH
Citation: Mt. Huisman et al., P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir, MOLEC PHARM, 59(4), 2001, pp. 806-813
The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons
Authors: Veldkamp, AI Harris, M Montaner, JSG Moyle, G Gazzard, B Youle, M Johnson, M Kwakkelstein, MO Carlier, H van Leeuwen, R Beijnen, JH Lange, JMA Reiss, P Hoetelmans, RMW
Citation: Ai. Veldkamp et al., The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons, J INFEC DIS, 184(1), 2001, pp. 37-42
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study
Authors: Nieuwkerk, PT Sprangers, MAG Burger, DM Hoetelmans, RMW Hugen, PWH Danner, SA van der Ende, ME Schneider, MME Schrey, G Meenhorst, PL Sprenger, HG Kauffmann, RH Jambroes, M Chesney, MA de Wolf, F Lange, JMA
Citation: Pt. Nieuwkerk et al., Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, ARCH IN MED, 161(16), 2001, pp. 1962-1968
Nevirapine plus didanosine: Once or twice daily combination?
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Reiss, P Lange, JMA Kwakkelstein, MO Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Nevirapine plus didanosine: Once or twice daily combination?, J ACQ IMM D, 25(1), 2000, pp. 93-95
Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen
Authors: Sparidans, RW Hoetelmans, RMW Beijnen, JH
Citation: Rw. Sparidans et al., Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen, J CHROMAT B, 742(1), 2000, pp. 185-192
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study, AIDS, 14(9), 2000, pp. F103-F110
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
Authors: van Praag, RME Weverling, GJ Portegies, P Jurriaans, S Zhou, XJ Turner-Foisy, ML Sommadossi, JP Burger, DM Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir, AIDS, 14(9), 2000, pp. 1187-1194
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Lange, JMA Danner, SA Foudraine, NA Kwakkelstein, MO Reiss, P Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals, AIDS, 14(8), 2000, pp. F77-F82
No drug-drug interaction between nelfinavir or indinavir and mefloquine inHIV-1-infected patients
Authors: Schippers, EF Hugen, PWH den Hartigh, J Burger, DM Hoetelmans, RMW Visser, LG Kroon, FP
Citation: Ef. Schippers et al., No drug-drug interaction between nelfinavir or indinavir and mefloquine inHIV-1-infected patients, AIDS, 14(17), 2000, pp. 2794-2795
Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men
Authors: Taylor, S van Heeswijk, RPG Hoetelmans, RMW Workman, J Drake, SM White, DJ Pillay, D
Citation: S. Taylor et al., Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men, AIDS, 14(13), 2000, pp. 1979-1984
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
Authors: Gisolf, EH Enting, RH Jurriaans, S de Wolf, F van der Ende, ME Hoetelmans, RMW Portegies, P Danner, SA
Citation: Eh. Gisolf et al., Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine, AIDS, 14(11), 2000, pp. 1583-1589
Risultati: 1-25 | 26-43